Piceatannol

Piceatannol is a naturally occurring stilbenoid, a class of plant polyphenol built on the stilbene skeleton ^[2]. It is a hydroxylated analogue of the better-known compound resveratrol, carrying one additional hydroxyl group, and is described chemically as a tetrahydroxystilbene with the formula C14H12O4; its sugar-bound form is called astringin ^[1][3].

The compound occurs in a range of plants, including grapes and red wine, passion fruit seeds, white tea, Japanese knotweed, the bark of Norway spruce, and rhubarb ^[1]. In addition to being obtained directly from these sources, piceatannol can be produced within the body from resveratrol, which cytochrome P450 enzymes convert to piceatannol by adding a hydroxyl group ^[1].

Much of the scientific interest in piceatannol comes from a broad set of activities observed largely in cell and animal studies. It is a strong antioxidant, reported in some comparisons to exceed resveratrol, and it shows anti-inflammatory, antidiabetic, neuroprotective, and cardioprotective effects in preclinical models ^[3]. In cancer research it has suppressed the growth of many tumor cell types and triggered programmed cell death through cell-cycle arrest and the suppression of signaling pathways such as NF-kB and JAK-STAT ^[1]. It is perhaps best known pharmacologically as an inhibitor of Syk, the spleen tyrosine kinase, which has made it a widely used laboratory tool for probing immune-cell signaling ^[1]. It has also been shown to inhibit the formation of fat cells and to bind estrogen receptors, the latter meaning it can in some settings stimulate estrogen-dependent cells ^[1].

Several limitations temper these findings. Piceatannol is rapidly metabolized in the body into glucuronide and sulfate conjugates, and its bioavailability is low, in fact lower than that of resveratrol, which complicates translating laboratory results into humans ^[1][3]. Most of the evidence remains preclinical, human clinical data are limited, and piceatannol is treated as a dietary polyphenol and research compound rather than an approved therapeutic ^[1][3].

Human safety data is limited but no major toxicity has been flagged at supplement-level intakes. As with resveratrol, it may affect drug-metabolizing enzymes and could have mild blood-thinning or estrogenic activity. People on medications or with hormone-sensitive conditions should be cautious given the thin data.